Discontinued — last reported Q2 '25
Idexx Laboratories Other Non-Current Assets increased by 10.9% to $47.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.2%, from $41.02M to $47.27M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 6.0% CAGR.
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Often contains strategic minority investments in technology partners or long-term tax-related items.
other_non_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.07M | $43.73M | $40.64M | $45.85M | $46.45M | $40.13M | $38.12M | $35.25M | $36.10M | $42.11M | $50.16M | $50.83M | $47.77M | $53.05M | $43.77M | $41.02M | $39.54M | $38.98M | $42.64M | $47.27M |
| QoQ Change | — | +14.9% | -7.1% | +12.8% | +1.3% | -13.6% | -5.0% | -7.5% | +2.4% | +16.7% | +19.1% | +1.3% | -6.0% | +11.1% | -17.5% | -6.3% | -3.6% | -1.4% | +9.4% | +10.9% |
| YoY Change | — | — | — | — | +22.0% | -8.2% | -6.2% | -23.1% | -22.3% | +4.9% | +31.6% | +44.2% | +32.3% | +26.0% | -12.8% | -19.3% | -17.2% | -26.5% | -2.6% | +15.2% |